| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
758 |
513 |
$219K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,689 |
1,807 |
$199K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,274 |
845 |
$131K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,078 |
405 |
$122K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,768 |
2,076 |
$107K |
| 80053 |
Comprehensive metabolic panel |
7,908 |
5,451 |
$70K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,209 |
1,610 |
$42K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,125 |
913 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
409 |
321 |
$13K |
| 71045 |
Radiologic examination, chest; single view |
735 |
470 |
$12K |
| 80061 |
Lipid panel |
1,984 |
1,729 |
$11K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
131 |
72 |
$10K |
| 70450 |
Computed tomography, head or brain; without contrast material |
96 |
51 |
$7K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,629 |
2,224 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,192 |
1,345 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
481 |
431 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
879 |
651 |
$4K |
| 80305 |
|
504 |
324 |
$4K |
| G0378 |
Hospital observation service, per hour |
34 |
24 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
100 |
95 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,510 |
5,766 |
$3K |
| 86769 |
|
326 |
156 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,016 |
1,843 |
$3K |
| 80050 |
General health panel |
79 |
77 |
$2K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
15 |
14 |
$2K |
| 71250 |
|
20 |
13 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,285 |
667 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,193 |
792 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
628 |
328 |
$980.65 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
451 |
70 |
$813.14 |
| 84484 |
|
1,430 |
673 |
$564.00 |
| 85610 |
|
1,659 |
808 |
$546.99 |
| 36415 |
Collection of venous blood by venipuncture |
10,434 |
6,809 |
$493.12 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
525 |
388 |
$389.10 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
284 |
112 |
$367.15 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
150 |
24 |
$355.49 |
| 84439 |
|
453 |
403 |
$292.85 |
| 82607 |
|
320 |
294 |
$285.87 |
| 81003 |
|
3,632 |
2,597 |
$197.61 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
26 |
13 |
$192.37 |
| Q3014 |
Telehealth originating site facility fee |
13 |
13 |
$177.76 |
| 83880 |
|
116 |
76 |
$155.44 |
| 86063 |
|
129 |
124 |
$128.02 |
| 82553 |
|
119 |
67 |
$96.17 |
| 81025 |
|
289 |
188 |
$87.62 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
205 |
95 |
$84.82 |
| 83735 |
|
1,014 |
662 |
$77.34 |
| 83690 |
|
628 |
355 |
$32.90 |
| 82550 |
|
230 |
143 |
$13.32 |
| 86706 |
|
63 |
54 |
$10.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
469 |
286 |
$7.53 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
491 |
231 |
$0.41 |
| 83605 |
|
74 |
36 |
$0.00 |
| 87340 |
|
40 |
38 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
17 |
12 |
$0.00 |
| 86704 |
|
39 |
37 |
$0.00 |
| 86701 |
|
27 |
25 |
$0.00 |
| 86803 |
|
39 |
38 |
$0.00 |
| 82043 |
|
68 |
65 |
$0.00 |
| 85651 |
|
40 |
26 |
$0.00 |
| 85730 |
|
17 |
13 |
$0.00 |
| 81015 |
|
14 |
12 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
20 |
13 |
$0.00 |
| 86592 |
|
13 |
12 |
$0.00 |
| 82570 |
|
74 |
68 |
$0.00 |
| 84550 |
|
118 |
112 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
26 |
12 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
42 |
38 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
42 |
38 |
$0.00 |